Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsA new virtual platform called Nosis is going national with a fresh take on substance use disorder (SUD) recovery — one that focuses on the body, not just the mind. Using labs, health coaches, and dietitians, Nosis targets biomarkers, nutrition, sleep, and metabolic health to support people in recovery. It's cash-pay for now, but the startup has its sights set on payer reimbursement down the road.
A new virtual platform called Nosis is launching in all 50 states with a distinctive approach to substance use disorder (SUD) recovery: treat the whole body, not just the addiction. Founded by Duffy Fallon — who is himself in recovery — Nosis uses lab testing across 85+ biomarkers, health coaches, and registered dietitians to address the metabolic, nutritional, and lifestyle factors that often go unaddressed in traditional SUD treatment. The platform doesn't prescribe medications for opioid use disorder or replace existing care teams; instead, it fills a gap by focusing on physical health as a recovery enabler.
The core offering is a 12-week program covering nutrition, movement, sleep, stress, and behavior change, supported by coaches who are themselves in recovery. Nosis plans to add GLP-1s for weight management and off-label craving support in early 2027.
By the Numbers:
Why it matters: People with SUD frequently struggle with comorbid conditions like poor sleep, inflammation, and hormonal imbalances — issues that can intensify cravings and derail recovery. By addressing these biological factors, Nosis aims to make recovery more sustainable, offering a model that could reshape how the industry thinks about holistic SUD care.
